REPEVAX ®

Available from October 2004, for pre-school use in children aged 4-5 years.

Abbreviated vaccine composition: dTaP/IPV (low-dose Diphtheria, Tetanus and Pertussin; inactivated Polio).

Contains:

• Purified Diphtheria toxoid (2 I.U.)

• Purified Tetanus toxoid (20 I.U.)

• Purified Pertussis toxoid (PT)

• Inactivated Polio virus, types 1/2/3 (40, 8 and 32 Dantigen units respectively)

• Aluminium phosphate

• Formaldehyde

• 2-phenoxyethanol (phenol) - a preservative

• Polysorbate 80 - an emulsifier

• Polyribosylribitol - an artificial sweetener

• The inactivated polio virus is cultured on Vero (African green monkey kidney) cells

• Neomycin, streptomycin and polymyxin B - antibiotics

Undesirable effects (as reported by Dept of Health and Aventis Pasteur ® ):

• Injection site pain; redness; swelling

• Headache

• Rigors; febrile convulsions and pain

• Myalgia; arthralgia; joint swelling

• Fever

• Diarrhoea & vomiting

• Lymph node swelling

• Allergic/anaphylactic reactions

• Rash, urticaria

• Guillain-Barré syndrome has been reported after vaccination containing tetanus toxoid

Side effects of the vaccine include adverse reactions to all components.